JPM
JPMorgan Chase & Co.
JPM's fundamentals are strong, but it looks expensive: trading at 14x earnings, above its usual 12x. Analysts expect earnings growth.
NXDT
NexPoint Diversified Real Estate Trust
There isn't enough reported data to score NXDT yet.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
NXDT Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| N/A | |
| N/A |
NXDT's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like NXDT.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
NXDT PE Valuation
NXDT has no meaningful PE right now: it lost money over the past year.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
NXDT Forward outlook
There aren't enough analyst estimates for NXDT to show an outlook.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over NXDT on earnings quality, reporting a profit while its opponent remains loss making.
NXDT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$1.48 | +$0.76 |
| Q1 2026 | -$2.47 | -$0.98 |
| Q4 2025 | -$2.81 | -$1.53 |
| Q3 2025 | -$2.28 | -$0.76 |
| Q2 2025 | -$2.24 | +$0.89 |
| Q1 2025 | -$1.49 | +$1.80 |
| Q4 2024 | -$1.28 | +$1.98 |
NXDT is still losing money, but far less than before: $1.48 per share over the past year, against $3.29 at its worst in early 2024.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM has the edge over NXDT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over NXDT on profitability, with a higher operating margin.
NXDT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $19.3M | -8.1% |
| Q1 2026 | $22.9M | -21% |
| Q4 2025 | $18.4M | -29% |
| Q3 2025 | $17.5M | -21% |
| Q2 2025 | $21M | -5.6% |
| Q1 2025 | $29.1M | +127% |
| Q4 2024 | $25.9M | +17% |
| Q3 2024 | $22.2M | +80% |
NXDT's revenue has slid since its 2022 peak: $19M last quarter, down 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 11% | +12 points |
| Q1 2026 | 15% | -3.9 points |
| Q4 2025 | -19% | -22 points |
| Q3 2025 | -19% | +7.7 points |
| Q2 2025 | -0.6% | -3.3 points |
| Q1 2025 | 19% | +17 points |
| Q4 2024 | 3.6% | -40 points |
| Q3 2024 | -27% | -23 points |
NXDT's operating margin was 11% last quarter, up 12 points from the same quarter a year ago.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
NXDT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$4.6M | -6277% |
| Q1 2026 | -$498K | -107% |
| Q4 2025 | $1.2M | +$5.3M |
| Q3 2025 | $835K | +68% |
| Q2 2025 | $75K | +$5.6M |
| Q1 2025 | $7.1M | +$9.6M |
| Q4 2024 | -$4.1M | +$1.7M |
| Q3 2024 | $497K | -79% |
NXDT has the edge over JPM on cash flow, with more consistent year-over-year improvement.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over NXDT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
NXDT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +21% | +10.4M shares |
| 1 year | +32% | +14.8M shares |
| 3 years | +63% | +23.3M shares |
NXDT has 60M diluted shares, up 32% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | $515,000 |
| Q1 2026 | $2.3M |
| Q4 2025 | $1.1M |
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
NXDT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -0.7x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
| Q4 2025 | -0.5x | Net Cash |
| Q3 2025 | -0.3x | Net Cash |
| Q2 2025 | -0.3x | Net Cash |
| Q1 2025 | -0.5x | Net Cash |
| Q4 2024 | -0.8x | Net Cash |
| Q3 2024 | -0.5x | Net Cash |
NXDT has the edge over JPM on leverage, with a lower net debt burden relative to earnings.
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
NXDT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 29.4 | Oversold |
| Stochastic | 5.6 | Oversold |
NXDT's weekly RSI is 29 (oversold) and its Stochastic is 6 (oversold).
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
NXDT PE vs Financial Services Sector
| Metric | NXDT | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
NXDT has no meaningful PE right now: it lost money over the past year.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over NXDT on trend strength, trading above more of its moving averages.
NXDT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.48 | 32% below |
| 20 week MA | $4.93 | 38% below |
| 50 week MA | $4.64 | 34% below |
| 100 week MA | $4.43 | 31% below |
| 200 week MA | $6.29 | 51% below |
NXDT is in a downtrend: it's below all five of its weekly moving averages, and 51% below its 200-week average.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has the edge over NXDT on returns for 2026, with the stronger performance.
NXDT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $17.8 | $10.5 | -41% |
| 2021 | $10.5 | $13.9 | +33% |
| 2022 | $13.9 | $11.8 | -15% |
| 2023 | $11.8 | $7.95 | -33% |
| 2024 | $7.95 | $6.37 | -20% |
| 2025 | $6.37 | $3.88 | -39% |
| 2026 YTD | $3.88 | $3.06 | -21% |
NXDT has finished four years in a row lower, and it's down 21% so far in 2026.